1. Home
  2. ITOS vs NRIM Comparison

ITOS vs NRIM Comparison

Compare ITOS & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • NRIM
  • Stock Information
  • Founded
  • ITOS 2011
  • NRIM 1990
  • Country
  • ITOS United States
  • NRIM United States
  • Employees
  • ITOS N/A
  • NRIM N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • NRIM Savings Institutions
  • Sector
  • ITOS Health Care
  • NRIM Finance
  • Exchange
  • ITOS Nasdaq
  • NRIM Nasdaq
  • Market Cap
  • ITOS 323.2M
  • NRIM 369.8M
  • IPO Year
  • ITOS 2020
  • NRIM N/A
  • Fundamental
  • Price
  • ITOS $9.17
  • NRIM $73.78
  • Analyst Decision
  • ITOS Strong Buy
  • NRIM
  • Analyst Count
  • ITOS 4
  • NRIM 0
  • Target Price
  • ITOS $32.50
  • NRIM N/A
  • AVG Volume (30 Days)
  • ITOS 692.7K
  • NRIM 24.5K
  • Earning Date
  • ITOS 11-15-2024
  • NRIM 10-23-2024
  • Dividend Yield
  • ITOS N/A
  • NRIM 3.29%
  • EPS Growth
  • ITOS N/A
  • NRIM 22.45
  • EPS
  • ITOS N/A
  • NRIM 5.86
  • Revenue
  • ITOS $35,000,000.00
  • NRIM $141,590,000.00
  • Revenue This Year
  • ITOS $271.18
  • NRIM N/A
  • Revenue Next Year
  • ITOS N/A
  • NRIM $3.03
  • P/E Ratio
  • ITOS N/A
  • NRIM $13.27
  • Revenue Growth
  • ITOS N/A
  • NRIM 12.70
  • 52 Week Low
  • ITOS $8.41
  • NRIM $41.82
  • 52 Week High
  • ITOS $18.75
  • NRIM $78.00
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 46.37
  • NRIM 59.76
  • Support Level
  • ITOS $8.41
  • NRIM $63.68
  • Resistance Level
  • ITOS $9.14
  • NRIM $78.00
  • Average True Range (ATR)
  • ITOS 0.49
  • NRIM 2.75
  • MACD
  • ITOS 0.21
  • NRIM 0.72
  • Stochastic Oscillator
  • ITOS 71.58
  • NRIM 70.53

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About NRIM Northrim BanCorp Inc

Northrim BanCorp Inc is a bank holding company. The company operates in two segments: Community Banking and Home Mortgage Lending. It generates maximum revenue from the Community Banking segment. It offers to spend and save products such as checking, savings, money market accounts, debit cards, cashback rewards, and credit cards. It also includes loans and credit lines, mortgage loans, investment, and plan products.

Share on Social Networks: